Double Medical Technology Hits Day Low Amid Price Pressure at CNY 42.56

Double Medical Technology, Inc. experienced a notable decline today, with its stock price dropping by 4.99% as of March 20, 2026. The stock reached an intraday low of CNY 42.56, reflecting a challenging trading session. Over the past week, the stock has seen a decrease of 5.81%, and its performance over the last month shows a decline of 10.21%. Despite these short-term fluctuations, Double Medical has demonstrated strong performance over the past year, achieving a return of 28.85%, significantly outperforming the China Shanghai Composite, which returned 16.08%. The company has reported impressive financial metrics, including a net profit growth of 27.79% and a robust operating cash flow of CNY 710.24 million. With a market capitalization of CNY 16,653 million, Double Medical operates within the Pharmaceuticals & Biotechnology sector and maintains a price-to-earnings ratio of 46.00. The company’s return on equity stands at 16.07%, indicating effective management of shareholder funds. As the market continues to react to various factors, Double Medical's performance metrics remain a focal point for stakeholders.